Efficacy of Supplement Adjuvant Capecitabine in HR+/HER2- Breast Cancer Patients With High Risks
Abroad (travel likely)RecruitingPHASE3
Conditions
Breast Cancer · Chemotherapy Effect
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
the Second Affiliated Hospital of Zhejiang Univercity School of Medicine, Hanzhou, Zhejiang, China
Contact: Study coordinator (Jianan Wang, Doctor)Contact: Study coordinator (Weilin Wang, Doctor)